Abstract

CD103+CD11b+ dendritic cells (DCs) are unique to the intestine, but the factors governing their differentiation are unclear. Here we show that transforming growth factor receptor 1 (TGFβR1) has an indispensable, cell intrinsic role in the development of these cells. Deletion of Tgfbr1 results in markedly fewer intestinal CD103+CD11b+ DCs and a reciprocal increase in the CD103CD11b+ dendritic cell subset. Transcriptional profiling identifies markers that define the CD103+CD11b+ DC lineage, including CD101, TREM1 and Siglec-F, and shows that the absence of CD103+CD11b+ DCs in CD11c-Cre.Tgfbr1fl/fl mice reflects defective differentiation from CD103CD11b+ intermediaries, rather than an isolated loss of CD103 expression. The defect in CD103+CD11b+ DCs is accompanied by reduced generation of antigen-specific, inducible FoxP3+ regulatory T cells in vitro and in vivo, and by reduced numbers of endogenous Th17 cells in the intestinal mucosa. Thus, TGFβR1-mediated signalling may explain the tissue-specific development of these unique DCs.

Details

Title
TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine
Author
Bain, C C 1   VIAFID ORCID Logo  ; Montgomery, J 2 ; Scott, C L 3 ; Kel, J M 4 ; Girard-Madoux, M J H 4 ; Martens, L 5   VIAFID ORCID Logo  ; Zangerle-Murray, T F P 6 ; Ober-Blöbaum, J 7 ; Lindenbergh-Kortleve, D 8 ; Samsom, J N 8 ; Henri, S 9 ; Lawrence, T 9 ; Saeys, Y 10 ; Malissen, B 9   VIAFID ORCID Logo  ; Dalod, M 9   VIAFID ORCID Logo  ; Clausen, B E 7   VIAFID ORCID Logo  ; Mowat, A McI 2 

 Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK; The University of Edinburgh/MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK 
 Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK 
 Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK; Laboratory of Myeloid Cell Ontogeny and Functional Specialization, VIB-UGent Center for Inflammation Research, Ghent 927, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium 
 Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands 
 Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium; Data Mining and Modeling for Biomedicine, VIB Inflammation Research Center, Ghent, Belgium 
 Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK; Faculty of Biology, Medicine and Health and Manchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK 
 Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany 
 Laboratory of Pediatrics, Division of Gastroenterology and Nutrition, Erasmus Medical Center, Rotterdam, The Netherlands 
 Centre d’Immunologie de Marseille-Luminy, Aix Marseille Université UM2, INSERM, U1104, CNRS UMR7280, Marseille, France 
10  Data Mining and Modeling for Biomedicine, VIB Inflammation Research Center, Ghent, Belgium; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium 
Pages
1-12
Publication year
2017
Publication date
Sep 2017
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1940962249
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.